Catecholamine prodrugs, Parkinson's disease treatment, Lundbeck
Summary
The European Patent Office published patent application EP3972971A1 for Lundbeck covering novel catecholamine prodrug compositions for treating Parkinson's disease. The A1 publication indicates the application passed formal examination and is now publicly available. The patent names Morten Jørgensen, Martin Juhl, and Klaus Jensen Gjervig as inventors.
What changed
The EPO published patent EP3972971A1 granting Lundbeck exclusive rights to catecholamine prodrug compositions for Parkinson's disease treatment. The patent covers A61P 25/16 therapeutic uses under IPC classification C07D 221/08 and C07H 17/02. The published claims define the prodrug chemical structure and its pharmaceutical applications.
For pharmaceutical companies and drug developers, this patent creates potential licensing opportunities or may necessitate design-around strategies for Parkinson's treatments in the European market. The designated states cover all EU member states plus Switzerland, Norway, and Turkey. Patent holders should monitor the nine-month opposition period following publication.
What to do next
- Monitor for patent validation in specific countries of interest
- Review claims for freedom-to-operate analysis
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASES
Publication EP3972971A1 Kind: A1 Apr 01, 2026
Applicants
H. Lundbeck A/S
Inventors
JØRGENSEN, Morten, JUHL, Martin, JENSEN, Klaus, Gjervig
IPC Classifications
C07D 221/08 20060101AFI20251219BHEP C07H 17/02 20060101ALI20251219BHEP A61P 25/00 20060101ALI20251219BHEP A61P 25/16 20060101ALI20251219BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.